Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

BA-BE Studies: SOP for Management of Trial Equipment Calibration Logs – V 2.0

Posted on By

BA-BE Studies: SOP for Management of Trial Equipment Calibration Logs – V 2.0

Standard Operating Procedure for Management of Trial Equipment Calibration Logs in BA/BE Studies

Department BA-BE Studies
SOP No. SOP/BA-BE/133/2025
Supersedes SOP/BA-BE/133/2022
Page No. Page 1 of 9
Issue Date 17/04/2025
Effective Date 20/04/2025
Review Date 17/04/2026

1. Purpose

To define a standardized procedure for managing and maintaining calibration logs of equipment used in bioavailability/bioequivalence (BA/BE) studies, ensuring all trial equipment is calibrated, traceable, and fit for intended use throughout the study period.

2. Scope

This SOP applies to all equipment and instruments used at clinical and bioanalytical sites involved in BA/BE trials, including but not limited to centrifuges, freezers, thermometers, ECG

machines, balances, and pipettes.

3. Responsibilities

  • Calibration Coordinator: Maintains calibration schedules, performs verification, and records results.
  • Department Heads: Ensure no uncalibrated equipment is used during study conduct.
  • QA Officer: Reviews calibration logs during audits and ensures compliance with SOP.
  • Clinical/Bioanalytical Personnel: Use only calibrated and qualified instruments.
See also  BA-BE Studies: SOP for Reviewing Reference Product Literature - V 2.0

4. Accountability

The Head of Facility/Operations is accountable for ensuring that all critical equipment used in BA/BE studies is regularly calibrated and documented, and that no uncalibrated equipment is used during trial procedures.

5. Procedure

5.1 Identification of Equipment Requiring Calibration

  1. Maintain a master list of equipment requiring periodic calibration using Annexure-1: Equipment Master Calibration List.
  2. Equipment must be categorized based on usage:
    • Critical (e.g., balances, pipettes, temperature devices)
    • Supportive (e.g., water baths, centrifuges)

5.2 Calibration Schedule and Planning

  1. Create a calibration schedule for each equipment item based on manufacturer recommendations and regulatory requirements.
  2. Use Annexure-2: Equipment Calibration Planner to track due dates.
  3. Calibrations must be performed:
    • Prior to study initiation
    • Annually or as per validation report
    • After repair or relocation

5.3 Calibration Procedure and Documentation

  1. Use certified external agencies or trained internal personnel for calibration.
  2. Document each calibration in Annexure-3: Equipment Calibration Log including:
    • Date of calibration
    • Next due date
    • Calibration result
    • Deviation (if any)
    • Calibration certificate reference
  3. Affix calibration status label on equipment with:
    • Calibration date
    • Due date
    • Technician initials
See also  BA-BE Studies: SOP for ECG Monitoring Before Dosing - V 2.0

5.4 Handling of Calibration Failures

  1. Immediately tag equipment as “OUT OF SERVICE”.
  2. Do not use equipment until recalibrated and qualified.
  3. Document action taken in Annexure-4: Calibration Deviation Report.

5.5 Record Retention and Audit Preparedness

  1. Retain all calibration records and certificates for at least 5 years or per sponsor requirements.
  2. Ensure availability of logs for regulatory audits and inspections.
  3. QA must perform quarterly review of calibration compliance using Annexure-5: Calibration Audit Checklist.

6. Abbreviations

  • BA: Bioavailability
  • BE: Bioequivalence
  • QA: Quality Assurance
  • SOP: Standard Operating Procedure

7. Documents

  1. Equipment Master Calibration List – Annexure-1
  2. Equipment Calibration Planner – Annexure-2
  3. Equipment Calibration Log – Annexure-3
  4. Calibration Deviation Report – Annexure-4
  5. Calibration Audit Checklist – Annexure-5

8. References

  • ICH E6(R2) – Good Clinical Practice
  • WHO TRS 937 Annex 4 – Equipment Qualification
  • 21 CFR Part 58 – Good Laboratory Practice
See also  BA-BE Studies: SOP for Handling of Vomiting or Spitting Cases Post-Dose - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Equipment Master Calibration List

Equipment ID Name Location Frequency Calibration Agency
EQ-01 Precision Balance Bio Lab Annually ABC Calibrations

Annexure-2: Equipment Calibration Planner

Equipment ID Due Date Planned Date Status Remarks
EQ-01 30/04/2025 25/04/2025 Scheduled Ready

Annexure-3: Equipment Calibration Log

Date Equipment ID Result Next Due Calibrated By
25/04/2024 EQ-01 Pass 25/04/2025 Ajay Verma

Annexure-4: Calibration Deviation Report

Date Equipment ID Issue Action Taken Closed By
15/03/2025 EQ-02 Drift in readings Recalibrated QA Manager

Annexure-5: Calibration Audit Checklist

Date Auditor Equipment Reviewed Findings Action Required
01/04/2025 Sunita Reddy Freezers, Balances Compliant None

Revision History:

Revision Date Revision No. Details Reason Approved By
15/01/2022 1.0 Initial release Regulatory requirement QA Head
17/04/2025 2.0 Updated with deviation reporting and audit checklist Internal QA Review QA Head
BA-BE Studies V 2.0 Tags:Absolute bioavailability, AUC (area under the curve), Bioavailability, Bioequivalence, Bioequivalence criteria, CDSCO bioequivalence norms, Clinical trial registration, Cmax (maximum concentration), Confidence interval %, Crossover study design, EMA bioequivalence requirements, Ethics committee approval, FDA bioequivalence guidelines, Generic drug approval, Good Clinical Practice (GCP), Good Laboratory Practice (GLP), Half-life (t½), ICH E(R) compliance, In vitro dissolution, In vivo studies, Informed consent process, Pharmacodynamics, Pharmacokinetics, Randomized controlled trial, Regulatory submission process, Relative bioavailability, Sample size calculation, Therapeutic equivalence, Tmax (time to maximum concentration), Washout period

Post navigation

Previous Post: Analytical Method Development: Oxidation-Reduction Titration Development – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version